retatrutide obesity triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Lilly's triple agonist, retatrutide, delivered
Pay in 4 interest-free payments of $7.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12






:max_bytes(150000):strip_icc()/Health-GettyImages-2112991930-7aba42b37c8641d3a76cb03100b26dda.jpg)

















